Sirisha L Mushti

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Vascular Endothelial Growth Factor

Immune Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Sriram Subramaniam, Hong Zhao, Miao Zhao, Youwei Bi, Guansheng Liu, Jianghong Fan, Oluseyi Adeniyi, Rosane Charlab, Dubravka Kufrin, Matthew D Thompson, Kristin Jarrell, Doris Auth, Steven J Lemery, Richard Pazdur, Paul G Kluetz, Lola A Fashoyin-Aje
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vaibhav Kumar, Leslie Doros, Margaret Thompson, Sirisha L Mushti, Rosane Charlab, Elizabeth I Spehalski, Hong Zhao, Matthew D Thompson, Shenghui Tang, Richard Pazdur, Steven J Lemery, Marc R Theoret, Lola A Fashoyin-Aje
FDA Approval Summary: Ripretinib for advanced gastrointestinal stromal tumor. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sirisha L Mushti, Flora Mulkey, Shenghui Tang, Harpreet Singh, Steven J Lemery, Kirsten B Goldberg, Rajeshwari Sridhara, Patricia Keegan, Paul G Kluetz, Richard Pazdur, Marc R Theoret, Julia A Beaver
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy. Current oncology reports 22 (11) (2020)